We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Weak at the knees

3 May 2018 By Carol Ryan

Shares in the artificial hip maker dropped 6 pct after it warned of slower revenue growth and flat profit margins. Incoming CEO Namal Nawana inherits a good portfolio of products in promising markets. His most pressing task is to quickly to reverse S&N’s sickly sales record.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)